Difficulty: Medium
Average Score: 66%
Practice
Addition of which of the following drugs would be appropriate for the patient at this time?
Correct answer
A
Rationale
Step-by-step rationale for the correct answer (A: Pegvisomant):
1. Patient likely has acromegaly due to elevated growth hormone levels.
2. Pegvisomant is a growth hormone receptor antagonist used to treat acromegaly by blocking the effects of growth hormone.
3. This drug would be appropriate to normalize the patient's growth hormone levels and improve symptoms.
Summary of why other choices are incorrect:
- B: Degarelix is a gonadotropin-releasing hormone antagonist used in prostate cancer, not for acromegaly.
- C: Leuprolide is a gonadotropin-releasing hormone agonist used in various conditions like prostate cancer and endometriosis, not for acromegaly.
- D: Cosyntropin is a synthetic form of adrenocorticotropic hormone used in diagnostic testing for adrenal function, not for acromegaly treatment.
1. Patient likely has acromegaly due to elevated growth hormone levels.
2. Pegvisomant is a growth hormone receptor antagonist used to treat acromegaly by blocking the effects of growth hormone.
3. This drug would be appropriate to normalize the patient's growth hormone levels and improve symptoms.
Summary of why other choices are incorrect:
- B: Degarelix is a gonadotropin-releasing hormone antagonist used in prostate cancer, not for acromegaly.
- C: Leuprolide is a gonadotropin-releasing hormone agonist used in various conditions like prostate cancer and endometriosis, not for acromegaly.
- D: Cosyntropin is a synthetic form of adrenocorticotropic hormone used in diagnostic testing for adrenal function, not for acromegaly treatment.